The New TAVR NCD Explained: What Changed for Heart Teams, Operators, and Programs
from The Murmur Pod Hosted by MurmurMD
The new TAVR National Coverage Determination brings some of the biggest changes structural heart programs have seen in years. In this MurmurMD discussion, Dr. Andrei Pop, Dr. Jeremiah Depta, and Samantha Ramos break down the new CMS TAVR NCD and what it means for patients, operators, and valve programs. The conversation covers the removal of Coverage with Evidence Development for symptomatic severe aortic stenosis, new requirements for asymptomatic patients, major changes to heart-team evaluation, single-operator TAVR, operator volume requirements, removal of prior hospital volume criteria, registry participation, quality improvement, and how programs should respond operationally. KEY TOPICS • Symptomatic severe AS no longer under CED • Asymptomatic severe AS covered only through CMS-approved CED studies • Coverage gap before the asymptomatic protocol is approved • One in-person operator evaluation instead of two separate specialty visits • Heart-team decision-making still required • Single-operator TAVR now allowed • New operator volume requirements • Removal of prior hospital volume thresholds • On-site surgical and ICU infrastructure requirements • TAVR registry no longer specifically mandated • Registry participation vs broader CQI requirements • Aortic regurgitation and moderate AS coverage questions • How programs should interpret and implement the new flexibility 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA CHAPTERS 00:00 – What changed in the new TAVR NCD 02:23 – Heart-team evaluation and single-operator TAVR 05:23 – Asymptomatic severe AS and CED coverage 14:28 – One visit, one operator, and program workflow 28:32 – New TAVR operator volume requirements 36:41 – New program and satellite-site possibilities 37:58 – Registry requirements and quality improvement 45:30 – Aortic regurgitation and moderate AS coverage 50:25 – Low-flow, low-gradient AS and heart-team judgment 52:18 – What TAVR programs should do now 55:18 – Why thoughtful CMS comments mattered 58:01 – Closing thoughts #TAVR #TAVRNCD #CMS #StructuralHeart #AorticStenosis #HeartTeam #TAVRProgram #Medicare #Reimbursement #ValveProgram #InterventionalCardiology #MurmurMD
Embed this episode
No transcript yet.